Microbix strikes deal for major new Chinese vaccine joint venture
This article was originally published in Scrip
Executive Summary
Microbix Biosystems has signed an agreement with a state-owned Chinese pharmaceutical enterprise to set up a joint venture in China for the production of seasonal and pandemic flu vaccines.